Influence of Reptin on acute pancreatitis model of the rat

Authors

  • Chol Kang Researcher, Pyongyang University of Medical Sciences, Pyongyang, Democratic People’s Republic of korea.
  • Hun Ryong Researcher, Pyongyang University of Medical Sciences, Pyongyang, Democratic People’s Republic of korea.
  • Song-Chol Mun Researcher, Pyongyang University of Medical Sciences, Pyongyang, Democratic People’s Republic of korea.
  • Gun-Son Ri Researcher, Pyongyang University of Medical Sciences, Pyongyang, Democratic People’s Republic of korea.

Keywords:

Leptin, SAP

Abstract

Background and Aim: In acute pancreatitis, hyperproduction of inflammatory mediators, including inflammatory cytokines, exacerbation of tissue injury due to microcirculatory disturbances, secondary activation of inflammatory cells in distant organs, and the cascade are the pathogenic basis of pancreatitis severity. Therefore, inhibition of pancreatic enzyme activity, blocking production, and preventing the activation of inflammatory cells is a practical way to prevent the development of severe acute pancreatitis and multiorgan failure. In our study, we sought to elucidate the effect of leptin on a rat model of severe acute pancreatitis. Methods: We prepared an acute pancreatitis model in rats by intraperitoneal injection of 20 μg/kg of leptin and single injection of 0.1 mL/100g of bile into a pancreatic duct extending from the duodenal papilla, measured survival, serum amylase activity, MPO activity in pancreatic tissue, SOD activity and MDA content, and observed the histopathological findings of pancreatic tissue. Results: Pre-administration of 20 μg/kg leptin improved the survival of rats, decreased serum amylase activity, MPO activity in pancreatic tissue, increased MDA content, increased SOD activity, and improved the histopathological features of pancreatic tissue.

References

Bakker O et al., Extrapancreatic necrosis without pancreatic parenchymal necrosis: a separate entity innecrotising pancreatitis? Gut 62, 1475-1480. 2013

Ding S P et al., A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World. J. Gastroenterol. 9(3), 584~589, 2014.

Frossard J et al., The role of intercellular adhesion molecule and neutrophils in acute pancreatitis and pancreatitis- associated lung injury. Gastroenterology. 116, 694-701, 2013.

Hackert T. et al., Platelete function in acute experimental pancreatitis induced by ischemia-repefusion. Br. J. Surg. 92(6), 724~728, 2005.

Inoue K et al., Further evidence for endothelin as an important madiator of pancreatic and intestinal ischemia in severe acute pancreatitis. Pancreas. 26(3), 218~223, 2008.

Laszlo Czako, et al., The pathogenesis of L-arginine-induced acitenecrotizing pancreatitis: Infla㎜atory mediators and endogenous cholecystokinin]. J. Physiol. 94, 43~50, 2011.

Leindler L et al., Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas. 29(2), 157~161, 2010.

Konturek PC, Jaworek J, Maniatoglou A, et al. Leptin modulates the inflammatory response in acute pancreatitis. Digestion. 2002, 65(3): 149-160.

La Cava A, Matarese G. The weight of leptin immunity. Nature reviews. Immunology, 2004, 4(5), 371-379.

Sanchez-Margalet V, Martin-Romero C, Santos-Alvarez J, et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol. 2003, 133(1): 11-19.

Gonzalez A, Merino B, Marroqui L, et al. Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual beta-cells. Endocrinology, 2013, 154(10): 3515-3524.

Dossin O. Laboratory tests for diagnosis of gastrointestinal and pancreatic diseases. Top Comp Anim Med, 2011, 26(2): 86-97.

Downloads

Additional Files

Published

2022-08-25

Issue

Vol. 11 No. 2 (2022)

Section

Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.